Evidence map›Paper›PMID 42713103›Full record

ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2026

Yu Xue, Wenting Huang, Sijia Liu, Xiaoxu Liu, Qingjie Min, Xuefeng Liu, Chaoqun Chen, Qimin Zhan

Abstract read
In one paragraph

Article in Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yu XueInstitute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
Wenting HuangInstitute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
Sijia LiuInstitute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
Xiaoxu LiuInstitute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
Qingjie MinInstitute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
Xuefeng LiuInstitute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
Chaoqun ChenInstitute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.
Qimin ZhanInstitute of Cancer Stem Cell, Dalian Medical University, Dalian 116044, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Esophageal cancer has a poor prognosis and limited treatment options. Ferroptosis, an iron-dependent cell death pathway, is a promising therapeutic target; however, its significance in esophageal cancer remains largely unexplored. Here, we investigated the prognostic significance of ferroptosis-related genes in esophageal cancer and identified a key functional regulator that may serve as a therapeutic target. Methods: We analyzed ferroptosis-related gene expression profiles with The Cancer Genome Atlas-Esophageal Carcinoma (TCGA-ESCA) cohort and constructed a prognostic risk model using LASSO Cox regression analysis. Among the genes in this model, GTP cyclohydrolase 1 ( Results: A prognostic model consisting of nine ferroptosis-related genes ( Conclusions: This study established a ferroptosis-related prognostic model for esophageal cancer and identified

Indexed as

drug sensitivityEsophageal cancerferroptosisGCH1prognostic model

Identifiers

PMID42713103
PMCPMC13551363

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.